Benjamin Graham fit · Defensive deep-value investing
Is PTC Therapeutics, Inc. (PTCT) a Benjamin Graham Stock?
Meets only 2/7 Graham criteria - likely overpriced or unstable.
35/100
DNot a fit
2/7 criteria passed
+2 sector-quality lift. Top-quintile within its sector on 1 of 5 quality metrics. Raw pillar score 33 → lifted to 35 before grade derivation.
Benjamin Graham's Criteria, Applied to PTCT
P/E ≤ 15
key-
P/B ≤ 1.5
key-
Current ratio ≥ 2
2.4x
Debt / Equity ≤ 1
-
5y profitable
keyNo
Earnings yield ≥ 7%
-3.2%
Revenue growing
33.9%
How PTCT Scores on Other Strategies
Live Financial Snapshot
Market cap
$6.13B
P/E (TTM)
-
ROIC (TTM)
-2.38%
Gross margin
77.84%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is PTCT's Benjamin Graham fit score?
PTCT scores 35/100 on our Benjamin Graham fit engine - grade D. Meets only 2/7 Graham criteria - likely overpriced or unstable.
Does Benjamin Graham actually own PTCT?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends PTCT.
How often is this score updated?
PTCT's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends PTCT.